A novel glycogene-related signature for prognostic prediction and immune microenvironment assessment in kidney renal clear cell carcinoma
This glycogene-based signature provides a robust tool for predicting prognosis, TME characteristics, and therapeutic responses in KIRC, offering potential clinical utility in patient management.
Authors
- Xueting Ren (ORCID: https://orcid.org/0000-0002-9437-1560)
- Shuai Lin (ORCID: https://orcid.org/0000-0002-4089-5721)
- Mingjing Zhou (ORCID: https://orcid.org/0009-0007-7816-7045)
- Peinan Liu (ORCID: https://orcid.org/0000-0002-5685-2064)
- Huafeng Kang
- Hanxiao Cui (ORCID: https://orcid.org/0000-0002-2549-0750)
- Zihao Li (ORCID: https://orcid.org/0009-0007-3696-3297)
- Danni Zhao
- Xuyan Zhao (ORCID: https://orcid.org/0009-0004-4360-8574)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1080/07853890.2025.2495762
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52